Fidia Pharma USA Inc
Jake Montelibano is an accomplished sales executive with extensive experience in the pharmaceutical and medical device industries. Currently serving as the Executive District Sales Manager at Fidia Pharma USA Inc since January 2017, Jake has earned the Pegasus Club Award three times as the top District Manager in the Northeast US, specializing in medical devices, orthobiologics, and regenerative medicine. Previously, Jake held leadership roles at Endo Pharmaceuticals and Auxilium Pharmaceuticals, achieving accolades such as the Circle of Excellence Award and the President's Club Award in various capacities focused on specialty sales and biologics. Jake's career also includes significant contributions as a District Manager at Shionogi Inc. and Sucampo Pharmaceuticals, where notable recognitions, including multiple District Manager of the Year awards, were attained. Jake's educational background includes a degree from New York University.
Fidia Pharma USA Inc
Fidia Pharma USA Inc is a wholly-owned subsidiary of the Italian pharmaceutical manufacturer Fidia Farmaceutici S.p.A., an established leader in the hyaluronic acid (HA) market segment. Fidia Pharma USA is focused on continually expanding Fidia’s position in the U.S. and Canadian market, while upholding the company's mission to provide consumers with innovative products that offer quality, safety and performance, establishing a sound strategic presence of Fidia in the US consistently with the Company's mission and strategy pillars. Drawing on the strengths of the parent company, Fidia Pharma USA product portfolio focuses primarily on therapeutic areas such as joint healthcare and tissue repair. Fidia Pharma USA Inc is headquartered in Parsippany, NJ.